March 3, 2021
A Message from Janet Hadar
Looking Back on a Year of COVID-19 at the UNC Medical Center.
March 3, 2021
Looking Back on a Year of COVID-19 at the UNC Medical Center.
March 3, 2021
First-year college students are reporting symptoms of depression and anxiety significantly more often than they were before the coronavirus pandemic, according to a study co-authored by Krista Perreira, PhD, professor in the UNC Department of Social Medicine.
March 3, 2021
Please read this letter from Wesley Burks, MD, Dean of the UNC School of Medicine and CEO of UNC Health Care, on the one-year anniversary of the first documented case of COVID-19 in North Carolina.
March 3, 2021
Co-workers across the UNC Health system reflect on the year that has passed since the first COVID-19 case was reported in North Carolina.
March 2, 2021
UNC-Chapel Hill research, led by Allison Aiello, PhD, and Emily Ciccone, MD, shows that individuals previously infected with SARS-CoV-2 develop a significant antibody response to the first dose of mRNA-based COVID-19 vaccines.
March 2, 2021
Joseph Grover, MD, assistant professor in UNC's Department of Emergency Medicine and medical director for Orange County Emergency Services, is the study's lead author.
February 26, 2021
Phillip Clapp, PhD, member of the Center for Environmental Medicine, Asthma, and Lung Biology, explains the research behind double-masking and how to make sure your mask fits properly.
February 23, 2021
UNC School of Medicine alum Kizzmekia Corbett, PhD, NIH scientific lead for COVID-19 vaccine development, was named to the list as a rising star and innovator in the scientific community.
February 19, 2021
Wes Wallace, MD, and G.W. Barker, Jr., RN, are both members of North Carolina 1 (NC-1), a federal Disaster Medical Assistance Team (DMAT) based in North Carolina.
February 17, 2021
More than 1,500 patients have received the treatment so far.
February 9, 2021
Using a novel in vivo research model containing human lung tissue, UNC School of Medicine scientists led by Victor Garcia, PhD, and Angela Wahl, PhD, demonstrated that the broad spectrum, experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection in human tissue in the lab.
February 3, 2021
In March, Devin Hubbard's days were filled with phone calls, Zoom meetings, and design tests as he and his team at FastTraCS worked around the clock to engineer new Personal Protective Equipment (PPE) designs in response to COVID-19. Ten months later, as millions of Americans adjust to the "new normal" of pandemic life, Hubbard and his colleagues are busier than ever. They have successfully engineered a frame that can improve both the fit and comfort of existing face masks.